Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3982 Target Snapshot

Tyrosine-protein kinase Fer · SINGLE PROTEIN · Homo sapiens

1,681Compounds
343Assays
18Approved Drugs
940.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P16591. Use UniProt P16591 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P16591 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tyrosine-protein kinase Fer as ChEMBL target CHEMBL3982, mapped to UniProt P16591. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tyrosine-protein kinase Fer
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3982
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P16591
Tyrosine-protein kinase Fer
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tyrosine-protein kinase Fer is the right protein anchor across sources, using UniProt P16591 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein kinase Fer
UniProt AccessionP16591
Component TypeProtein
Sequence Length822 aa

Tyrosine-protein kinase Fer

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tyrosine-protein kinase Fer, mapped to UniProt P16591. Sequence length is 822 aa.

Mapped IDP16591
Review nameTyrosine-protein kinase Fer
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

18
Approved
6
Phase III
23
Phase II
13
Phase I
Assay Mix

Activity Type Distribution

IC5075.0
KI475.0
KD390.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL388978 9.69 IC50 0.203 Preclinical
CHEMBL5597957 9.49 IC50 0.32 Preclinical
CHEMBL5598347 9.46 IC50 0.35 Preclinical
CHEMBL5598005 9.38 IC50 0.42 Preclinical
CHEMBL4461851 9.31 IC50 0.49 Preclinical
CHEMBL5596211 9.31 IC50 0.49 Preclinical
CHEMBL3545311 8.89 IC50 1.3 Approved
CHEMBL5188373 8.89 IC50 1.3 Preclinical
CHEMBL509032 8.85 Kd 1.4 Preclinical
CHEMBL461876 8.8 Ki 1.585 Preclinical
Distribution

pChEMBL Value Distribution

14
5.0
37
5.5
76
6.0
50
6.5
28
7.0
27
7.5
14
8.0
13
8.5
7
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

ENTRECTINIB
CHEMBL1983268
Approved 2019
LORLATINIB
CHEMBL3286830
Approved 2018
GILTERITINIB
CHEMBL3301622
Approved 2018
BRIGATINIB
CHEMBL3545311
Approved 2017
NERATINIB
CHEMBL180022
Approved 2017
NINTEDANIB
CHEMBL502835
Approved 2014
CERITINIB
CHEMBL2403108
Approved 2014
BOSUTINIB
CHEMBL288441
Approved 2012
CRIZOTINIB
CHEMBL601719
Approved 2011
Assay Landscape

Assay Landscape

343
Total Assays
130
Tested Compounds
2
Assay Types
Binding — 342 assays, 113 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 224 55 7.0
assay format 47 19 7.5
cell-based format 44 5 7.0
subcellular format 27 34 6.2
Functional — 1 assays, 130 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 130 6.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine